Sign in
WithdrawnEarly phase 1

Skin Immunity Sample Collection Involving Blisters and Biopsies

Key facts

Who runs it
National Institute of Allergy and Infectious Diseases (NIAID)
Where
Bethesda, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Early phase 1
Started
9 Dec 2024
Ended
10 Dec 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Blister induction
  • Skin Biopsies
Record updated
13 December 2024
Why it stopped
Study closed by PI, no enrollment.

Who can take part

Age
7 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (7)Hide the full registry criteria

Who cannot take part

  • Current or prior (within 3 months) use of immunomodulatory drugs (e.g., chemotherapy, steroids), except if approved by the principal investigator
  • For individuals undergoing blister or skin biopsy procedures, history of keloid formation
  • Any condition that, in the opinion of the investigator, contraindicates participation in the study
  • Current or prior (within 3 months) anticoagulant or anti-platelet therapy (other than aspirin or non-steroidal anti-inflammatory drugs [NSAIDs])
  • The following exclusion criteria apply to all subjects:
  • Pregnancy

Other criteria

  • INCLUSION CRITERIA:; Meets one of the following:; has documentation of HIES or CGD (patient populations); or; does not have clinically apparent evidence of an immune defect or history of invasive or recurrent S. aureus infections (healthy volunteers); Between the following age limits (inclusive):; 18 and 65 years old for healthy volunteers; 7 and 65 years old for patients with CGD; 18 and 65 years old for patients with HIES; Willing to allow storage of blood, RNA, bacterial and fungal cultures, and other tissue samples for future research; Able to provide informed consent

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United States

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

The way the body heals and protects itself from getting sick is called the immune response. Some people with weak immune systems get sick often or get rashes and skin infections. Researchers want to find out how the immune system and skin problems are related so they can help these people.

Objective:

To learn about how immune response and skin healing are related to each other.

Eligibility:

People ages 18-65 with hyper IgE syndrome or Job syndrome or people ages 7-65 with chronic granulomatous disease. Healthy volunteers ages 18 65 are also needed.

Design:

Participants will be screened with:

Medical history

Physical exam

Possible urine tests

Participants will have 1 to 3 visits within about a week. Visits will include the following:

Participants will have a wells device strapped to the inside of the forearm. It will suction the skin and pull the top layer away to form 8 blisters. The skin over the blisters and the liquid inside will be collected.

Participants will have up to 4 skin biopsies. A sharp tool will remove a small plug of skin from the forearm.

Participants may have blood and urine tests.

The skin on participants skin will be rubbed with a cotton swab.

Some participants will have an overnight visit. They will have the blister device placed back on the arm. The wells will be lined up over the blister wounds. The wells will be filled with either saline or the participant s blood serum. The device will be covered and left on the arm for up to 24 hours. Doctors will periodically remove some liquid from the wells.

The 2 groups in the trial

  • 1Other group

    Blister Induction

    Treatment: Blister induction

  • 2Other group

    Skin Biopsies

    Treatment: Skin Biopsies

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 December 2024